Revenue Breakdown
Composition ()
No data
Revenue Streams
Chemed Corp (CHE) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Short-term core , accounting for 25.5% of total sales, equivalent to $157.52M. Other significant revenue streams include Water restoration and Independent contractors. Understanding this composition is critical for investors evaluating how CHE navigates market cycles within the Healthcare Facilities & Services industry.
Profitability & Margins
Evaluating the bottom line, Chemed Corp maintains a gross margin of 32.67%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 15.74%, while the net margin is 12.00%. These profitability ratios, combined with a Return on Equity (ROE) of 25.28%, provide a clear picture of how effectively CHE converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, CHE competes directly with industry leaders such as PACS and BKD. With a market capitalization of $5.80B, it holds a significant position in the sector. When comparing efficiency, CHE's gross margin of 32.67% stands against PACS's 15.33% and BKD's 14.69%. Such benchmarking helps identify whether Chemed Corp is trading at a premium or discount relative to its financial performance.
